News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
58 Results
Type
Article (2)
Press Release (56)
Section
Business (13)
Deals (4)
Drug Development (1)
News (18)
Tag
Earnings (5)
Events (13)
FDA (1)
Healthcare (5)
IPO (3)
Medical device (4)
Medtech (4)
Mergers & acquisitions (1)
Metabolic disorders (2)
Obesity (2)
People (9)
United States (7)
Date
Last 30 days (3)
Last 365 days (18)
2024 (18)
2023 (9)
2022 (3)
2021 (10)
2020 (5)
2019 (1)
2018 (4)
2017 (3)
2016 (1)
2015 (1)
2014 (1)
2012 (1)
2011 (1)
Location
Delaware (1)
Europe (1)
Massachusetts (5)
Texas (1)
58 Results for "allurion".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
News
Allurion Announces Submission of First Three Modules of Premarket Approval Application to the U.S. Food and Drug Administration for the Allurion Balloon
October 23, 2024
·
5 min read
Press Releases
Allurion Announces Publication of Meta-Analysis Demonstrating the Safety and Effectiveness of the Allurion Program for Weight Loss
October 1, 2024
·
4 min read
Business
Allurion Announces the Appointment of Ojas A. Buch as Chief Operating Officer
Allurion Technologies, Inc. today announced the appointment of Ojas A. Buch as its new Chief Operating Officer.
June 5, 2024
·
5 min read
Genetown
Allurion Announces Publication of New Data Demonstrating Lean Mass Gains in Patients Experiencing 14% Weight Loss
Allurion Technologies, Inc., a company dedicated to ending obesity, announced the publication of a study demonstrating an average lean mass gain of 5.6% in patients with an average weight loss of 14% at four months on the Allurion Program.
June 20, 2024
·
6 min read
Genetown
Allurion to Participate in Two Upcoming Investor Conferences in June 2024
Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced that it will be participating in two upcoming investor conferences.
May 29, 2024
·
2 min read
Business
Allurion Announces Preliminary First Quarter 2024 Results
Allurion Technologies, Inc. today announced preliminary, unaudited results for the first quarter 2024.
April 30, 2024
·
5 min read
Deals
Allurion Announces Pricing of $20 million Public Offering and Concurrent Private Placement
Allurion Technologies, Inc. today announced the pricing of an underwritten public offering of 14,406,508 shares of its common stock, par value $0.0001 per share (the “Shares”), and warrants to purchase 14,406,508 Shares.
June 28, 2024
·
6 min read
Press Releases
Allurion to Report Third Quarter 2024 Financial Results on November 13, 2024
October 30, 2024
·
1 min read
Business
Allurion Reports First Quarter 2024 Financial Results and Provides Business Update
Allurion Technologies, Inc. today announced its financial results for the first quarter ended March 31, 2024, and provided a business update.
May 14, 2024
·
11 min read
Press Releases
Allurion Presents Data From Largest Ever Real-World Experience of 19,428 Patients at The Obesity Society’s Annual Conference
November 4, 2024
·
5 min read
1 of 6
Next
